Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Tacrolimus in HCV Liver Transplant
NCT00260208Phase 4Terminated
- Sponsor
- Novartis
- Start
- Jan 2006
- Primary completion
- Sep 2010
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of cyclosporine in graft rejection, sponsored by Novartis. Started Jan 2006; status: terminated.
02
Drugs
cyclosporine
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00260208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260208.